Risks and Opportunities of AI in Clinical Drug Development
Due to COVID-19 the event has been postponed until 2021. Details forthcoming.
We have left the schedule up here for reference. These dates and times no longer apply.
Click on each event title for a full description and abstracts.
ML and AI in Clinical Development and Statistical Innovation — Wang Li, AbbVie.
Opportunities for AI in Healthcare — Lawrence Carin, Duke UniversityFind out more »
Bias from Treatment Contamination in Clinical Decision Rules — Amol Navathe, University of Pennsylvania.
Finding Natural Experiments in Observational Data — Adler Perotte, Columbia University.
Discussant — Jesse Berlin, Johnson & Johnson.Find out more »
Moderator: Jeannette M. Wing, Columbia University. Panelists: Graeme Archer, GlaxoSmithKline. Igor Jurisica, Krembil Research Institute & Univ of Toronto. Simon Tavaré, Columbia University.Find out more »